Survival Outcomes of Early-Stage Hormone Receptor-Positive Breast Cancer in Elderly Women

被引：0
|
作者：
Apoorve Nayyar
Paula D. Strassle
Kathleen Iles
Danielle Jameison
Jihane Jadi
Kandace P. McGuire
Kristalyn K. Gallagher
机构：
[1] University of Iowa Hospitals and Clinics,General Surgery Resident, Department of Surgery
[2] The University of North Carolina at Chapel Hill,Department of Surgery
[3] University of North Carolina at Chapel Hill,Department of Epidemiology, Gillings School of Global Public Health
[4] VCU School of Medicine,Department of Surgery
[5] Virginia Commonwealth University,Massey Cancer Center
来源：
Annals of Surgical Oncology | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4853 / 4860
页数：7
相关论文
共 50 条
  • [21] Trends in Locoregional Therapy in Older Women with Early-Stage Hormone Receptor-Positive Breast Cancer by Frailty and Life Expectancy
    Christina A. Minami
    Ginger Jin
    Rachel A. Freedman
    Mara A. Schonberg
    Tari A. King
    Elizabeth A. Mittendorf
    Annals of Surgical Oncology, 2024, 31 : 920 - 930
  • [22] Survival outcomes by hormone receptor expression in early-stage HER2-positive breast cancer.
    Sardesai, Sagar D.
    Kassem, Mahmoud
    Morgan, Evan
    Palettas, Marilly
    Stephens, Julie
    Williams, Nicole Olivia
    Stover, Daniel G.
    Van Deusen, Jeffery
    Wesolowski, Robert
    Lustberg, Maryam B.
    Ramaswamy, Bhuvaneswari
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [23] Are we there yet? Optimal duration of endocrine therapy in women with postmenopausal early-stage hormone receptor-positive breast cancer
    Symonds, Lynn K.
    Davidson, Nancy E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (11): : 1240 - 1242
  • [24] Outcome of adjuvant chemotherapy in elderly patients with early-stage, hormone receptor-positive, HER-2-negative breast cancer
    Ma, Sung Jun
    Oladeru, Oluwadamilola T.
    Singh, Anurag K.
    BREAST JOURNAL, 2020, 26 (10): : 2026 - 2030
  • [25] Effect of omission of surgery on survival in patients aged 80 years and older with early-stage hormone receptor-positive breast cancer
    de Boer, A. Z.
    de Glas, N. A.
    Marang-van De Mheen, P. J.
    Dekkers, O. M.
    Siesling, S.
    de Munck, L.
    de Ligt, K. M.
    Liefers, G. J.
    Portielje, J. E. A.
    Bastiaannet, E.
    BRITISH JOURNAL OF SURGERY, 2020, 107 (09) : 1145 - 1153
  • [26] Impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer
    Fowble, B.
    Fein, D.A.
    Hanlon, A.L.
    Eisenberg, B.L.
    Hoffman, J.P.
    Sigurdson, E.R.
    Daly, M.B
    Goldstein, L.J.
    International Journal of Radiation Oncology, Biology, Physics, 1996, 35 (04):
  • [27] Prognostic Tests in Early-Stage Hormone Receptor-Positive Breast Cancer: An Opportunity to Refine Personalized Cancer Care
    LeVasseur, Nathalie
    Gelmon, Karen A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (10) : 1816 - +
  • [28] Adherence to endocrine therapy in patients with hormone receptor-positive early-stage breast cancer: a retrospective study
    Yan, Yi-Dan
    Fu, Jie
    Gu, Zhi-Chun
    Lu, Jin-Song
    Su, Ying-Jie
    Lin, Hou-Wen
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (01) : 184 - 190
  • [29] The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer
    Fowble, B
    Fein, DA
    Hanlon, AL
    Eisenberg, BL
    Hoffman, JP
    Sigurdson, ER
    Daly, MB
    Goldstein, LJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (04): : 669 - 677
  • [30] Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer
    Jerez, Yolanda
    Herrero, Blanca
    Arregui, Marta
    Moron, Blanca
    Martin, Miguel
    Echavarria, Isabel
    FUTURE ONCOLOGY, 2020, 16 (17) : 1165 - 1177
12345